2024 annual financial data
Ligand Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -13.53%.
Operating income was -22,606,000 USD and net income was -4,032,000 USD.
Operating cash flow was 97,047,000 USD.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 167,133,000 USD
- Operating income
- -22,606,000 USD
- Net income
- -4,032,000 USD
- Operating cash flow
- 97,047,000 USD